Skip to main content
. 2007 Jun 20;45(8):2439–2445. doi: 10.1128/JCM.00577-07

TABLE 1.

Predictive values of HCV RNA levels and changes at different time points

Time point HCV RNA level Sensitivity (%)a Specificity (%)b PPV (%)c NPV (%)d
Baseline <400,000 IU/ml 32 100 100 51
Day 21 <10,000 IU/ml 71 100 100 70
Day 21 <100,000 IU/ml 87 76 84 80
Wk 4 <1,000 IU/ml 68 95 95 68
Wk 4 <15 IU/ml (negative) 48 100 100 58
Wk 4 <450,000 IU/ml 97 36 68 89
Wk 12 <50 IU/ml (negative) 93 95 97 91
Wk 12 <15 IU/ml (negative) 90 95 97 88
Second slopee >0.70 log IU/wk 74 91 92 71
Second slopee >0.35 log IU/wk 97 73 83 94
Second slopef >0.70 log IU/wk 71 95 96 70
Second slopef >0.35 log IU/wk 100 73 84 100
Decrease, day 4 >1.5 log IU 45 100 100 53
Decrease, wk 12 >2 log IU 100 50 74 100
a

Sensitivity, proportion of patients with SVR who had HCV RNA levels below, a slope value above, or HCV RNA reduction above the given limit.

b

Specificity, proportion of patients with non-SVR who did not have HCV RNA below, a slope value above, or HCV RNA reduction above the given limit.

c

PPV, proportion of patients with HCV RNA below, a slope value above, or HCV RNA reduction above the given limit who achieved SVR.

d

NPV, proportion of patients without HCV RNA below, a slope value above, or HCV RNA reduction above the given limit who did not achieve SVR.

e

Based on HCV RNA levels at days 7, 14, and 21.

f

Based on all HCV RNA values.